Neuralstem, Inc. News Headlines

CUR 
$1.85
*  
0.09
5.11%
Get CUR Alerts
*Delayed - data as of May 6, 2015  -  Find a broker to begin trading CUR now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By







An Expert's Opinion On Neuralstem's Phase 2 Results
3/20/2015 12:38:00 PM - Seeking Alpha






How Successful Was The Neuralstem Phase II Trial?
3/17/2015 8:23:00 AM - Seeking Alpha














NeoStem: The Levi Strauss Of Cell Therapy
2/12/2015 9:05:00 AM - Seeking Alpha






15 Biotech Names For 2015
1/5/2015 2:37:00 PM - Seeking Alpha


Genervon ALS drug shows encouraging results
10/20/2014 8:27:00 AM - Seeking Alpha


InVivo, Neuralstem Treat Spinal Cord Injury Patients
10/16/2014 1:53:00 PM - Seeking Alpha


Why Neuralstem Has Plenty Of Upside In The Short Term
8/26/2014 8:29:00 AM - Seeking Alpha






Behind The Promotion Of Northwest Bio
7/7/2014 9:35:00 AM - Seeking Alpha


An Early Valuation Of Neuralstem's NSI-189 For MDD
6/26/2014 9:34:00 AM - Seeking Alpha